Revenue: The sum of all revenue fields included for a company's operating activities.
Ginkgo Bioworks Holdings, Inc. (DNA) had Revenue of $227.04M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$227.04M |
$-547.03M |
|
$44.55M |
|
$182.50M |
|
$786.80M |
|
$-559.76M |
|
$12.25M |
|
$-547.51M |
|
$-518.68M |
|
$-547.03M |
|
$-547.03M |
|
$-547.03M |
|
$-518.18M |
|
$-559.76M |
|
$-448.88M |
|
51.90M |
|
51.90M |
|
$-10.54 |
|
$-10.54 |
|
| Balance Sheet Financials | |
$602.74M |
|
$203.72M |
|
$774.71M |
|
$1.38B |
|
$107.27M |
|
-- |
|
$554.12M |
|
$661.39M |
|
$716.06M |
|
$643.55M |
|
$716.06M |
|
54.37M |
|
| Cash Flow Statement Financials | |
$-319.58M |
|
$-62.24M |
|
$-1.74M |
|
$989.58M |
|
$605.74M |
|
$-383.84M |
|
$112.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.38% |
|
-246.54% |
|
-246.54% |
|
-197.71% |
|
-241.15% |
|
-240.94% |
|
$-381.48M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
10.12 |
|
36.08 |
|
-76.39% |
|
-85.00% |
|
-39.71% |
|
-76.39% |
|
$13.17 |
|
$-7.35 |
|
$-6.16 |
|